Africa is facing a pivotal moment in its role in clinical trial history. With ongoing improvements around infrastructure, continued investment, as well as being home to one of the world’s largest working age populations, the region is finally being recognised as a key contender in the clinical trials market. But for sponsors, challenges and hesitancy remain.
This paper will examine the dynamics of today’s clinical trial market in Africa, taking a closer look at the key challenges the region is facing including the differing regulatory requirements from country to country, as well as supply chain burdens and how sponsors can overcome them to unlock the continent’s growing potential.
